Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.77 | N/A |
| PEG Ratio (TTM) | -0.44 | N/A |
| P/S Ratio (TTM) | 0.92 | N/A |
| P/B Ratio (TTM) | 1.71 | N/A |
| P/FCF Ratio (TTM) | 11.66 | N/A |
| Price to 5YR AVG Earnings Ratio | 5.84 | N/A |
| Price to 5YR AVG FCF Ratio | 8.75 | N/A |
Profitability (55%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 7.57% | N/A |
| ROE (TTM) | 12.29% | N/A |
| Net Profit Margin (TTM) | 6.69% | N/A |
| ROIC 5YR AVG | 43.32% | N/A |
Growth (40%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -52.82% | -23.36% | 23.02% |
| Revenue | -4.29% | 2.67% | 12.23% |
| Net Income | -52.71% | -24.88% | 30.90% |
| Cash Flow | -25.61% | 68.31% | 113.01% |
Health (72%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.01 | N/A |
| Quick Ratio (TTM) | 1.41 | N/A |
| D/E Ratio (TTM) | 0.09 | N/A |
| Interest Coverage (TTM) | 11.58 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 4.32 | N/A |
| LTL to 5YR AVG FCF | 0.41 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.95% | N/A |